ACM Global Central Laboratory Continues to Expand Sales Force with the Appointment Steve Sisson and Chad Mills
Published: Mar 21, 2011
Steve, who is responsible for business development to ACM Global’s CRO and biotech clients in the Western US, has over twenty years of experience in clinical trials, ten of which have been in clinical lab sales. He began his career at Smith Kline Beecham as a protocol administrator, and also worked as a study manager, specimen processing manager, and finally account manager at SKB. He worked for eight years at Esoterix Central Laboratory and Quest. Steve worked most recently at Genzyme Genetics, where he was responsible for selling central pathology.
Chad; responsible for business development in the New England and Midwest territory, has over nine years in the clinical trials industry, all in business development. He began his career at Quest Diagnostics and was most recently at INC Research. He has been successful at a number of other CROs including I3 Research, Covance and Nextrials. Chad has spent his entire career in the New England market and hails from the Boston area. He is a graduate of the University of New Hampshire, with a degree in zoology.
Brian Clark, Senior Director, Business Development who heads up the team in North America said “we are delighted with the appointment of both Steve and Chad and welcome them to our growing sales team. Both bring extensive experience from their clinical trial and sales background and maintain ACM Global’s reputation for providing a team of dedicated and knowledgeable professionals.”
Chad Mills will be one of several ACM Global representatives attending the Outsourcing in Clinical Trials East Coast on March 9-10. The company will be exhibiting at booth #23, as well as the registration and lunch sponsors. You can arrange an appointment to meet Chad or another ACM Global representative at the show here.
About ACM Global Central Laboratory
ACM Global Central Laboratory offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s operations extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting. For more information, visit www.acmgloballab.com